Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.70 |
| ▸ | ALPI | P09923 | 1/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.70 |
| ▸ | XIAP | P98170 | 1/20 | 0.70 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.59 |
| ▸ | LTA4H | P09960 | 1/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.55 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | LAP3 | P28838 | 3/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | CTSC | P53634 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29595350 | 0.89 | SLC7A5 (0.56) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL8118 | 0.83 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL16398197 | 0.83 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL15671104 | 0.83 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| D-Phenylalanine SCHEMBL837632 | 0.83 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL23159186 | 0.83 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL16398196 | 0.83 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL385804 | 0.83 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL8119 | 0.83 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL1331985 | 0.83 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250230198-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING PROTEIN NANOWIRES WITH TUNABLE FUNCTIONALITY | YALE UNIVERSITY | 2025-07-17 | — | — | US | claimed |
| WO-2023147365-A1 | COMPOSITIONS AND METHODS FOR MAKING AND USING PROTEIN NANOWIRES WITH TUNABLE FUNCTIONALITY | YALE UNIVERSITY (US) | 2023-08-03 | — | — | WO | claimed |
| US-20260146265-A1 | CAS12 PROTEINS AND USES THEREOF | REFORGENE MEDICINE (CN) | 2026-05-28 | — | — | US | disclosed |
| EP-4737566-A1 | CAS12 PROTEIN AND USE THEREOF | Reforgene Medicine (CN) | 2026-05-06 | — | — | EP | disclosed |
| EP-4692338-A1 | CAS12 PROTEIN AND USE THEREOF | Guangzhou Reforgene Medicine Co., Ltd. (CN) | 2026-02-11 | — | — | EP | disclosed |
| EP-4692118-A1 | ADAM9-TARGETING HUMANIZED ANTIBODY AND ANTIBODY-DRUG CONJUGATE COMPRISING SAME AND USE THEREOF | Duality Biologics (Shanghai) Co., Ltd. (CN) | 2026-02-11 | — | — | EP | disclosed |
| US-20260009052-A1 | CAS12 PROTEINS AND USES THEREOF | GUANGZHOU REFORGENE MEDICINE CO., LTD. (CN) | 2026-01-08 | — | — | US | disclosed |
| US-20260001919-A1 | ADENO-ASSOCIATED VIRUS WITH ENGINEERED CAPSID | TENAYA THERAPEUTICS INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12435327-B2 | Genetically encoded tyrosine sulfation of proteins in eukaryotes | TRUSTEES OF BOSTON COLLEGE (MA) | 2025-10-07 | — | — | US | disclosed |
| US-20250270289-A1 | SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF | YALE UNIVERSITY | 2025-08-28 | — | — | US | disclosed |
| US-20250250585-A1 | CAPSIDS FOR PLAKOPHILLIN-2 GENE THERAPY | TENAYA THERAPEUTICS, INC. | 2025-08-07 | — | — | US | disclosed |
| US-11408007-B2 | Compositions and methods for biocontainment of microorganisms | YALE UNIVERSITY (US) | 2022-08-09 | — | — | US | disclosed |
| US-20220119793-A1 | Genetically Encoded Tyrosine Sulfation of Proteins in Eukaryotes | NATIONAL INSTITUTES OF HEALTH | 2022-04-21 | — | — | US | disclosed |
| US-20220111018-A1 | COMPOSITIONS AND METHODS FOR INHIBITING YEAST INFECTIONS | UNIVERSITY OF IDAHO (US) | 2022-04-14 | — | — | US | disclosed |
| US-20220105170-A1 | AFRICAN SWINE FEVER VACCINE | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2022-04-07 | — | — | US | disclosed |
| US-8883963-B2 | Peptidomimetics with glucagon antagonistic and GLP 1 agonistic activities | CADILA HEALTHCARE LIMITED (IN) | 2014-11-11 | — | — | US | disclosed |
| US-8841413-B2 | Antidiabetic compounds | CADILA HEALTHCARE LIMITED (IN) | 2014-09-23 | — | — | US | disclosed |
| US-20130225488-A1 | Antidiabetic Comppounds | CADILA HEALTHCARE LIMITED (IN) | 2013-08-29 | — | — | US | disclosed |
| WO-1996004297-A1 | SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS PEPTIDE COUPLING REAGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1996-02-15 | — | — | WO | disclosed |
| WO-1991005564-A1 | SYNTHESIS AND USE OF AMINO ACID FLUORIDES AS PEPTIDE COUPLING REAGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146265-A1 | CAS12 PROTEINS AND USES THEREOF | PHAX, STING1, TTLL12 | SLC7A5 1547/4885ALPI 1207/4885PKM 1314/4885 |
| US-20260001919-A1 | ADENO-ASSOCIATED VIRUS WITH ENGINEERED CAPSID | MYH9, MYL6, MYL12A | SLC7A5 1301/4885ALPI 3321/4885PKM 3897/4885 |
| US-20130225488-A1 | Antidiabetic Comppounds | GLP1R, GPR119, GIPR | SLC7A5 2003/4885ALPI 2098/4885PKM 2445/4885 |
| US-20250270289-A1 | SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF | CPSF1, CPSF6, CPSF7 | SLC7A5 444/4885ALPI 4180/4885PKM 36/4885 |
| US-20260009052-A1 | CAS12 PROTEINS AND USES THEREOF | RBM12, STING1, TTLL12 | SLC7A5 1370/4885ALPI 843/4885PKM 1206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.